Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer

Comparison of the Nottingham Prognostic Index and OncotypeDX© recurrence score in predicting outcome in estrogen receptor positive breast cancer

Introduction: Traditionally, Nottingham prognostic index (NPI) informed prognosis in patients with estrogen receptor positive, human epidermal growth factor receptor-2 negative, node negative (ER+/HER2-/LN-) breast cancer. At present, OncotypeDX© Recurrence Score (RS) predicts prognosis and response...

Full description

Bibliographic Details
Main Authors: Eoin P. Kerin, Matthew G. Davey, Ray P. McLaughlin, Karl J. Sweeney, Michael K. Barry, Carmel M. Malone, Sami Abd Elwahab, Aoife J. Lowery, Michael J. Kerin
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Breast
Subjects:
Breast cancer
Cancer surgery
Surgical oncology
Oncological outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977622001849

Internet

http://www.sciencedirect.com/science/article/pii/S0960977622001849

Similar Items